Debevoise advised agilon health and CD&R in secondary offering of agilon health common stock

16 September 2021

Debevoise & Plimpton LLP has advised agilon health, inc. and Clayton Dubilier & Rice, LLC in the $586.5 million underwritten secondary offering by certain selling stockholders of agilon health common stock. For more information, please see the company’s press release.

agilon health is transforming health care for seniors by empowering primary-care physicians to focus on the entire health of their patients. Through its partnerships and platform, agilon is leading the nation in creating a health care system built on the value of care, not the volume of fees.

The Debevoise team was led by capital markets partner Paul Rodel and included associates John Jacob, Benjamin Pedersen and Charlotte Walkovik, benefits partner Meir Katz and associate David Deutsch, corporate counsel Kim Le and tax associate Lillian Aston.